Ledger.Open graph →
SEC Form D · filed November 29, 2024

Tasca Therapeutics Corp

Offering
$70.2M
Sold
$24.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

E. Karol · Boston, MAExec · DirectorXu Wu · Boston, MADirectorMilenko Cicmil · Boston, MAExec · DirectorPraveen Tipirneni · Boston, MADirectorMichael Aberman · Boston, MADirectorDavid Fallace · Boston, MADirectorDrew King · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗